Although the effects of exogenous FGF21 treatment on acute and chronic colitis and colitis recovery and remission were not clearly investigated due to the complex effects of FGF21, we propose that targeting the FGF21 signaling pathway could be a promising strategy for treating IBD. The gene discussed is FGF21; the disease is colitis.